Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer (ZANTE)

This study has been completed.
Information provided by:
National Cancer Institute, Naples Identifier:
First received: December 22, 2006
Last updated: February 23, 2010
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)